Scientific Online Resource System

Conference Proceedings

Main Problems of Patients with Rare Diseases on the Territory of the Republic of Bulgaria

Marina Yordanova


Rare diseases are life-threatening and chronic conditions that occur in a limited number of patients. The problems with this group of patients are related to the lack of knowledge on the part of doctors and patients, which requires the cooperation of all individuals involved.
Rare diseases are a challenge both at European level and worldwide. Taking the issue seriously, all member countries have developed national plans and strategies to organize and plan activities to help and prevent illness. As a difficult and unpredictable area in healthcare, all interested parties are in the position of learners in the process of research and treatment. It is important to build strong relationships between medical professionals, patients and their loved ones, continuous communication and data exchange, trust in the work process to overcome a number of problems and obstacles in the field of rare diseases.
The article presents the author's survey on the attitudes of specialists in the field of rare diseases regarding the main problems of their patients. The aim of the study is to identify weaknesses in the system and to focus on measures to improve the problem-solving process. The analysis and evaluation of these attitudes should be the basis for the creation and implementation of effective changes by health authorities.


rare diseases, health problems, patients with rare diseases, orphan drugs, satisfaction

Full Text


Zlatareva A, Dissertation on "Financing and pharmacotherapy of rare diseases:" Sofia

Personal research in the thesis "Opportunities for increasing access to drugs for patients with rare diseases in the Republic of Bulgaria"

ORDINANCE № 10 of 24.03.2009 on the terms and conditions for payment for medicinal products under Art. 262, para. 5, item 1 of the Law on Medicinal Products in Human Medicine, Medical Devices and Dietary Foods for Special Medical Purposes

Ordinance on the conditions, rules and procedure for regulation and registration of the prices of medicinal products. In force since 30.04.2013. Adopted by Council of Ministers Decree No. 97 of 19.04.2013 / Council of Ministers.

National Council on Prices and Reimbursement of Medicinal Products. Positive drug list

Iskov G, Stefanov R., Miteva- Katrandzieva T – Challenges to orphan drugs access in Eastern Europe: the case of Bulgaria

Detiček A, Locatelli I, Kos M. Patient Access to Medicines for Rare Diseases in European Countries. Value Health. 2018 May;21(5):553-560. doi: 10.1016/j.jval.2018.01.007. Epub 2018 Mar 16. PMID: 29753352.

Young SP, Henderson E, Cheseldine DL, Wilson AS, Skan J/ Devepolment and assessment of a World Wide Web site for systemic lupus erythematosus patient information


Font Size